Scientists sound alarm over threat of untreatable gonorrhea in United States

February 9, 2012 By Bobbi Nodell, University of Washington
A stained sample of gonorrhea bacteria detected in a urinary tract specimen. Credit: CDC

(Medical Xpress) -- Researchers are continuing to sound the alarm on the growing threat of multi-drug resistant gonorrhea in the United States, according to a perspective  in the Feb. 9 issue of the New England Journal of Medicine.

In July of 2011, the U.S. Centers for Disease Control and Prevention released “Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates - United States, 2000-2010,” which signaled the potential for resistance to the cephalosporins, the last line of defense for treating .

The New England Journal of Medicine piece,  “The Emerging Threat of Untreatable Gonococcal Infection,” by Gail A. Bolan, director of the Division of STD Prevention at  the Centers for Disease Control and Prevention in Atlanta, P. Frederick Sparling, professor emeritus at  the University of North Carolina, Chapel Hill, and Judith N. Wasserheit, professor and vice chair of  the Department of Global Health at the University of Washington in Seattle, issues an urgent call to action to halt the continued increases in drug-resistant gonorrhea.

“It is time to sound the alarm,” said co-author Wasserheit. “Though there is no evidence yet of treatment failures in the United States, trends in decreased susceptibility coupled with a history of emerging resistance and reported treatment failures in other countries point to a likelihood of failures on the horizon and a need for urgent action.”

According to the article, gonorrhea is the second most commonly reported communicable disease in the , with an estimated incidence of more than 600,000 cases annually. It disproportionately affects some populations such as minorities who are marginalized because of race, ethnic group or sexual orientation.

Scientists note that Neisseria gonorrhoeae has always readily developed resistance to antimicrobial agents: it became resistant to sulfanilamide in the 1940s, penicillins and tetracyclines in the 1980s, and fluoroquinolones by 2007.  The treatment options recommended by the CDC are now limited to third-generation cephalosporins.

But the effectiveness of cephalosporins for treating gonorrhea has been decreasing rapidly. Through CDC’s Gonococcal Isolate Surveillance Project , researchers are seeing a 17-fold increase in elevated minimum inhibitory concentrations (MICs) -- a measure of drug susceptibility. MICs for oral cefixime went from 0.1 percent in 2006 to 1.7 percent in the first six months of 2011.

In the past, when the prevalence of antimicrobial resistance in the Gonococcal Isolate Surveillance Project  exceeded 5 percent, national treatment recommendations were changed to focus on other effective drugs. But currently, there are no other drugs.

The most prominent increases in drug susceptibility to gonorrhea continue to be among men who have sex with men, and in the West, according to the authors. They wrote that these geographic and demographic patterns are worrisome because they mirror those observed during the emergence of fluoroquinolone-resistant N. gonorrhoeae.

Scientists are calling on a collective effort from physicians, drug companies, and health care providers to help stop the emergence and spread of resistant gonorrhea.

“Investing in rebuilding our defenses against gonococcal infections now, with involvement of the health care, public health, and research communities, is paramount if we are to control the spread and reduce the consequences of cephalosporin-resistant strains,” the scientists wrote.

Explore further: Rise of antibiotic-resistant gonorrhea needs urgent action

Related Stories

Rise of antibiotic-resistant gonorrhea needs urgent action

September 19, 2011
Gonorrhea is evolving into a scourge resistant to most antibiotics, and urgent action is needed to combat this public health threat, states an editorial in CMAJ (Canadian Medical Association Journal).

Scientists discover first gonorrhea strain resistant to all available antibiotics

July 11, 2011
An international research team has discovered a strain of gonorrhea resistant to all currently available antibiotics. This new strain is likely to transform a common and once easily treatable infection into a global threat ...

Growing concern over drugs fed to animals

September 19, 2011
Drugs fed to animals to promote growth and prevent diseases may play a key role in the emergence of antibiotic resistant bacteria, microbiologists said Sunday.

Drug-resistant infections: A new epidemic, and what you can do to help

November 10, 2011
(Medical Xpress)—Are you aware that colds, flu, most sore throats and bronchitis are caused by viruses? Did you know that antibiotics do not help fight viruses and that using them for viral infections only decreases their ...

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.